In another retrospective study on 592 sporadic stage IV gastroenteropancreatic neuroendocrine tumors, it was found that higher serum NSE level at the time of the first consultation was associated with a more aggressive disease course which could be used for prognostic use (46). This evidence concerns the gene ENO2 and neuroendocrine neoplasm.